CBS 2019
CBSMD教育中心
中 文

双重抗血小板治疗持续时间

Abstract

Recommended Article

Safety and efficacy of the bioabsorbable polymer everolimus-eluting stent versus durable polymer drug-eluting stents in high-risk patients undergoing PCI: TWILIGHT-SYNERGY Dual Antiplatelet TherapyIs It Time to Cut the Cord With Aspirin? Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry Ticagrelor versus clopidogrel in patients with acute coronary syndromes Long-term dual antiplatelet-induced intestinal injury resulting in translocation of intestinal bacteria into blood circulation increased the incidence of adverse events after PCI in patients with coronary artery disease

Original Research07 December 2020

JOURNAL:Sci Rep. Article Link

Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease

Y-C Tung, C-T Kuo, C-J Chang et al. Keywords: bleeding risk; DAPT; CAD

Full Text PDF

网站资料更新中...